A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

NCT04712396 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)

Interventions

DRUG: Capivasertib
DRUG: Itraconazole

Sponsor

AstraZeneca

Collaborators

[object Object]